东吴证券:百济神州成长确定性较高,维持“买入”评级

格隆汇
Nov 18, 2024

东吴证券 研报指出, 百济神州 -U(688235.SH)Q3销售收入快速增长,经营性现金流转正。Q3 总收入达10.02亿美元(同比+28%,下同),2024Q1-Q3 收入分别为7.5/9.3/10.0亿美元(Q3环比+7.6%),欧美市场贡献超76%。其中,泽布替尼的全球销售达6.9亿美元(+93%),美国销售额5.04亿美元(+87%),主要得益于该产品在CLL患者中的使用增多。截至前...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10